About Exa Biosciences
Exa Biosciences is a private company based in Boston, Massachusetts, incorporated in 2023 in Delaware. It has reported $50,000 raised in one offering on Form D since August 2024. Its chief executive is Xun Chen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 31, 2024 | Aug 14, 2024 | $50,000of $400K target | 1 | $50,000 | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Exa Biosciences's Form D filed Aug 14, 2024.
XC
Xun Chen
Chief Executive Officer